{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:20:05Z","timestamp":1794900005535,"version":"4.9.1"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"32","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,8]]},"abstract":"<jats:p>\n                    Previous studies on the impact of medication use on the risk of erectile dysfunction (ED) have yielded controversial results. Therefore, this study aims to explore the association between the use of 20 different drugs and the risk of ED through cross-sectional research and Mendelian randomization (MR) analysis. We analyzed 3989 participants from the 2001 to 2004 National Health and Nutrition Examination Survey. Weighted multivariable logistic regression was used to analyze the association between medication use and the risk of ED. After propensity score matching, the association between the use of 20 different medications and the risk of ED was further assessed. Weighted restricted cubic splines were applied to evaluate the nonlinear relationship between the days of medication use and the risk of ED. Then, two-sample MR analysis was conducted to investigate the causal association between medication use and the risk of ED, with inverse variance weighting as the primary analytical method. Cross-sectional findings indicated salicylic acid derivatives (OR 3.28; 95% CI 1.27\u20138.50) and 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors (OR 1.34; 95% CI 1.01\u20131.79) were associated with higher ED risk, and that the duration of HMG CoA reductase inhibitor use had an S-shaped nonlinear relationship with ED risk (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0329). The results in the preliminary MR analysis further demonstrated a causal relationship between the use of salicylic acid (OR 1.23; 95% CI 1.00, 1.51) and derivatives or HMG CoA reductase inhibitors (OR 1.12; 95% CI 1.04, 1.21) and the increased risk of ED. The meta-analysis of the preliminary MR analysis and the validation analysis also confirmed this causal relationship. Our study suggests a causal association between the use of salicylic acid and derivatives or HMG-CoA reductase inhibitors and an increased risk of ED. Therefore, special caution should be exercised in applying these 2 classes of drugs to patients at high risk of ED or those already suffering from ED.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000043157","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T19:00:15Z","timestamp":1755198015000},"page":"e43157","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association between 20 medications and erectile dysfunction: Results from a cross-sectional study and Mendelian randomization analysis"],"prefix":"10.1097","volume":"104","author":[{"given":"Chengyi","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology, Tumor Hospital of Harbin Medical University, Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Tumor Hospital of Harbin Medical University, Harbin Medical University, Harbin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9747-2121","authenticated-orcid":false,"given":"Feng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Tumor Hospital of Harbin Medical University, Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261117","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(12)60520-0","article-title":"Erectile dysfunction.","volume":"381","author":"Shamloul","year":"2013","journal-title":"Lancet (London, England)"},{"key":"R2-20261117","doi-asserted-by":"crossref","first-page":"g129","DOI":"10.1136\/bmj.g129","article-title":"Erectile dysfunction.","volume":"348","author":"Muneer","year":"2014","journal-title":"BMJ"},{"key":"R3-20261117","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41443-022-00528-w","article-title":"Applications of artificial intelligence in the diagnosis and prediction of erectile dysfunction: a narrative review.","volume":"35","author":"Xiong","year":"2023","journal-title":"Int J Impot Res"},{"key":"R4-20261117","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12978-016-0249-2","article-title":"A community-based study on prevalence and correlates of erectile dysfunction among Kinondoni District Residents, Dar Es Salaam, Tanzania.","volume":"13","author":"Pallangyo","year":"2016","journal-title":"Reproductive Health"},{"key":"R5-20261117","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1743-6109.2008.01111.x","article-title":"Erectile dysfunction and mental health in a general population of older men.","volume":"6","author":"Korfage","year":"2009","journal-title":"J Sex Med"},{"key":"R6-20261117","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/postgradmedj-2017-135233","article-title":"Effect of prescription medications on erectile dysfunction.","volume":"94","author":"Razdan","year":"2018","journal-title":"Postgrad Med J"},{"key":"R7-20261117","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1464-410X.2011.10761.x","article-title":"Population-based study of erectile dysfunction and polypharmacy.","volume":"110","author":"Londo\u00f1o","year":"2012","journal-title":"BJU Int"},{"key":"R8-20261117","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jsxm.2021.05.016","article-title":"Erectile and ejaculatory dysfunction associated with use of psychotropic drugs: a systematic review.","volume":"18","author":"Trinchieri","year":"2021","journal-title":"J Sex Med"},{"key":"R9-20261117","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamapsychiatry.2023.2696","article-title":"Sexual dysfunction in schizophrenia: a systematic review and meta-analysis.","volume":"80","author":"Korchia","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"R10-20261117","doi-asserted-by":"crossref","first-page":"627278","DOI":"10.1155\/2012\/627278","article-title":"Erectile dysfunction and hypertension: impact on cardiovascular risk and treatment.","volume":"2012","author":"Javaroni","year":"2012","journal-title":"Int J Hypertension"},{"key":"R11-20261117","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2164\/jandrol.04191","article-title":"Factors affecting the increased prevalence of erectile dysfunction in Greek hypertensive compared with normotensive subjects.","volume":"27","author":"Doumas","year":"2006","journal-title":"J Androl"},{"key":"R12-20261117","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1742-1241.2010.02563.x","article-title":"Cardiovascular risk, drugs and erectile function \u2013 a systematic analysis.","volume":"65","author":"Baumh\u00e4kel","year":"2011","journal-title":"Int J Clin Pract"},{"key":"R13-20261117","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41569-021-00593-6","article-title":"Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs.","volume":"19","author":"Terentes-Printzios","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"R14-20261117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2020.07.009","article-title":"Erectile dysfunction and adherence to antihypertensive therapy: focus on \u03b2-blockers.","volume":"81","author":"Manolis","year":"2020","journal-title":"Eur J Internal Med"},{"key":"R15-20261117","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1745-7262.2006.00076.x","article-title":"Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients.","volume":"8","author":"Doumas","year":"2006","journal-title":"Asian J Androl"},{"key":"R16-20261117","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/sj.ijir.3901516","article-title":"Cardiovascular drug use and the incidence of erectile dysfunction.","volume":"19","author":"Shiri","year":"2007","journal-title":"Int J Impot Res"},{"key":"R17-20261117","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s10557-021-07197-9","article-title":"Effects of major antihypertensive drug classes on erectile function: a network meta-analysis.","volume":"36","author":"Farmakis","year":"2022","journal-title":"Cardiovasc Drugs Ther"},{"key":"R18-20261117","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3945\/an.115.009258","article-title":"Update on NHANES dietary data: focus on collection, release, analytical considerations, and uses to inform public policy.","volume":"7","author":"Ahluwalia","year":"2016","journal-title":"Adv Nutr"},{"key":"R19-20261117","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/ije\/dyx207","article-title":"Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities.","volume":"46","author":"Walker","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R20-20261117","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization.","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"R21-20261117","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/ije\/dyw127","article-title":"Commentary: two-sample Mendelian randomization: opportunities and challenges.","volume":"45","author":"Lawlor","year":"2016","journal-title":"Int J Epidemiol"},{"key":"R22-20261117","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.ijir.3900542","article-title":"Measurement of erectile dysfunction in population-based studies: the use of a single question self-assessment in the Massachusetts Male Aging Study.","volume":"12","author":"Derby","year":"2000","journal-title":"Int J Impot Res"},{"key":"R23-20261117","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1525-1497.2005.0076.x","article-title":"The validity of a single-question self-report of erectile dysfunction. Results from the Massachusetts Male Aging Study.","volume":"20","author":"O\u2019Donnell","year":"2005","journal-title":"J Gen Intern Med"},{"key":"R24-20261117","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amjmed.2006.06.010","article-title":"Prevalence and risk factors for erectile dysfunction in the US.","volume":"120","author":"Selvin","year":"2007","journal-title":"Am J Med"},{"key":"R25-20261117","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/andr.13443","article-title":"Effects of obesity-related anthropometric indices and body composition on erectile dysfunction mediated by coronary artery disease: a Mendelian randomization study.","volume":"12","author":"Bao","year":"2024","journal-title":"Andrology"},{"key":"R26-20261117","first-page":"293","article-title":"Association between body mass index, metabolic syndrome and common urologic conditions: a cross-sectional study using a large multi-institutional database from the United States.","volume":"55","author":"Suarez Arbelaez","year":"2197","journal-title":"Ann Med"},{"key":"R27-20261117","first-page":"1","article-title":"National health and nutrition examination survey: analytic guidelines, 1999\u20132010.","author":"Johnson","year":"2013","journal-title":"Vital Health Stat Series Data Eval Methods Res"},{"key":"R28-20261117","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/s41467-019-09572-5","article-title":"Genome-wide association study of medication-use and associated disease in the UK Biobank.","volume":"10","author":"Wu","year":"2019","journal-title":"Nat Commun"},{"key":"R29-20261117","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets.","volume":"16","author":"Santos","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"R30-20261117","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ajhg.2018.11.004","article-title":"GWAS identifies risk locus for erectile dysfunction and implicates hypothalamic neurobiology and diabetes in etiology.","volume":"104","author":"Bovijn","year":"2019","journal-title":"Am J Hum Genet"},{"key":"R31-20261117","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption.","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R32-20261117","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R33-20261117","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R34-20261117","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/gepi.21998","article-title":"Bias due to participant overlap in two-sample Mendelian randomization.","volume":"40","author":"Burgess","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R35-20261117","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jare.2023.05.008","article-title":"Insights into modifiable risk factors of erectile dysfunction, a wide-angled Mendelian Randomization study.","volume":"58","author":"Xiong","year":"2024","journal-title":"J Adv Res"},{"key":"R36-20261117","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2165\/00003495-198600324-00003","article-title":"Aspirin and related derivatives of salicylic acid.","volume":"32","author":"Clissold","year":"1986","journal-title":"Drugs"},{"key":"R37-20261117","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/bju.13264","article-title":"Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: results from the prostate cancer prevention trial.","volume":"117","author":"Patel","year":"2016","journal-title":"BJU Int"},{"key":"R38-20261117","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/bju.12231","article-title":"Common prescription medication use and erectile dysfunction: results from the Boston Area Community Health (BACH) survey.","volume":"112","author":"Kupelian","year":"2013","journal-title":"BJU Int"},{"key":"R39-20261117","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/bdi.12108","article-title":"Aspirin for treatment of lithium-associated sexual dysfunction in men: randomized double-blind placebo-controlled study.","volume":"15","author":"Saroukhani","year":"2013","journal-title":"Bipolar Disord"},{"key":"R40-20261117","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/jsm.12147","article-title":"COX-2-10aa-PGIS gene therapy improves erectile function in rats after cavernous nerve injury.","volume":"10","author":"Lin","year":"2013","journal-title":"J Sex Med"},{"key":"R41-20261117","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00345-010-0600-0","article-title":"Functional inhibition of erectile process in rats by indomethacin.","volume":"29","author":"Senbel","year":"2011","journal-title":"World J Urol"},{"key":"R42-20261117","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sj.bjp.0704675","article-title":"Regulation of human penile smooth muscle tone by prostanoid receptors.","volume":"136","author":"Angulo","year":"2002","journal-title":"Br J Pharmacol"},{"key":"R43-20261117","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1464-410X.2006.06530.x","article-title":"Effect of chronic lithium administration on endothelium-dependent relaxation of rat corpus cavernosum: the role of nitric oxide and cyclooxygenase pathways.","volume":"99","author":"Sadeghipour","year":"2007","journal-title":"BJU Int"},{"key":"R44-20261117","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1503\/cmaj.1020049","article-title":"Erectile dysfunction: management update.","volume":"170","author":"Fazio","year":"2004","journal-title":"CMAJ"},{"key":"R45-20261117","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/S0022-5347(05)68160-8","article-title":"Repeated PGE1 treatment enhances nitric oxide and erection responses to nerve stimulation in the rat penis by upregulating constitutive NOS isoforms.","volume":"162","author":"Escrig","year":"1999","journal-title":"J Urol"},{"key":"R46-20261117","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/eurheartj\/ehx566","article-title":"Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials.","volume":"39","author":"Koskinas","year":"2018","journal-title":"Eur Heart J"},{"key":"R47-20261117","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2710.1996.tb00006.x","article-title":"Men treated with hypolipidaemic drugs complain more frequently of erectile dysfunction.","volume":"21","author":"Bruckert","year":"1996","journal-title":"J Clin Pharm Ther"},{"key":"R48-20261117","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2165\/00002018-200932070-00005","article-title":"Statins and erectile dysfunction: results of a case\/non-case study using the French pharmacovigilance system database.","volume":"32","author":"Do","year":"2009","journal-title":"Drug Saf"},{"key":"R49-20261117","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s11154-022-09748-3","article-title":"The role of testosterone in male sexual function.","volume":"23","author":"Corona","year":"2022","journal-title":"Rev Endocr Metab Disorders"},{"key":"R50-20261117","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1111\/jsm.12521","article-title":"The effect of statins on erectile dysfunction: a meta-analysis of randomized trials.","volume":"11","author":"Kostis","year":"2014","journal-title":"J Sex Med"},{"key":"R51-20261117","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3390\/toxics10100627","article-title":"Statins and male fertility: is there a cause for concern?","volume":"10","author":"Omolaoye","year":"2022","journal-title":"Toxics"},{"key":"R52-20261117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5534\/wjmh.180015","article-title":"Statins and erectile dysfunction.","volume":"37","author":"Kostis","year":"2019","journal-title":"World J Men\u2019s Health"},{"key":"R53-20261117","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.jacl.2016.09.004","article-title":"The effects of statin treatment on adrenal and sexual function and nitric oxide levels in hypercholesterolemic male patients treated with a statin.","volume":"10","author":"Baspinar","year":"2016","journal-title":"J Clin Lipidol"},{"key":"R54-20261117","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.jacc.2019.09.026","article-title":"Trends in lipid, lipoproteins, and statin use among U.S. Adults: impact of 2013 cholesterol guidelines.","volume":"74","author":"Patel","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R55-20261117","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R56-20261117","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:02:36Z","timestamp":1794898956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":56,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043157","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"2025-02-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}